Fig. 4From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancerThe NNMT-related nomogram developed from GSE9891 dataset. The nomogram illustrated that NNMT had a larger contribution to OS than debulking statusBack to article page